SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announcedtoday that the China National Medical Products Administration (NMPA) has cleared the Investigational New Drug (IND) application for SCG101V, marking the first-ever investigational cell therapy to enter regulatory approved Phase 1/2 clinical trial for […]

Tam Jai International Crowned Grand Winner with 14 Awards at Employee Experience Awards 2025

Tam Jai International Co. Limited (“TJI” or the “Company”, together with its subsidiaries, the “Group”; HKEX stock code: 2217), one of the leading and renowned restaurant groups in Hong Kong, has been named theGrand Winner at the Employee Experience Awards 2025, Hong Kong (the “Awards”), securing 14 recognitions for its outstanding achievements. Mr Derek Wu,

Black Hawk Acquisition Corporation Amends Its Definitive Proxy Statement

(NasdaqGM:BKHAU), DANVILLE, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the “Company”) announced today that it filed a supplement to its definitive proxy statement, originally filed with the Securities and Exchange Commission on June 10, 2025, to amend the language of the Trust Amendment Proposal. Originally, the Trust Amendment Proposal

Advantech Unveils Next-Generation Edge AI Compute Solutions Powered by Qualcomm Snapdragon X Elite

Advantech is proud to introduce its latest suite of high-performance edge AI compute solutions powered by the Snapdragon® X Elite platform – theAOM-6731,AIMB-293, andSOM-6820. Built on this groundbreaking platform, these innovative products are engineered to meet the demanding requirements of modern industrial applications by delivering exceptional processing power, integrated AI acceleration with up to 45

The Keg Royalties Income Fund Announces Receipt of Interim Order and Filing of Special Meeting Materials in Respect of Proposed Transaction with Fairfax

(TSX:KEG-UN), Not for distribution to U.S. News wire services or dissemination in the U.S. VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund“) (TSX: KEG.UN) today announced that, further to the arrangement agreement entered into among the Fund, 1543965 B.C. Ltd. (the “Purchaser“), a subsidiary of Fairfax Financial

Investigation Opened on Behalf of BellRing Brands, Inc. (BRBR) Shareholders – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / July 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of BellRing Brands, Inc. ("BellRing Brands, Inc.") (NYSE:BRBR) concerning possible violations of federal securities laws. On May 6, 2025, BellRing Brands during its second quarter of 2025 earnings call revealed that certain customers

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Apple Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AAPL

(NASDAQ:AAPL), NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Apple Inc. (NASDAQ: AAPL) between June 10, 2024 and June 9, 2025, both dates inclusive (the “Class Period”), of the important August 19, 2025 lead plaintiff deadline. SO WHAT: If you

RCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”), of the importantAugust 11, 2025 lead plaintiff deadline. So what: If you purchased Rocket Pharmaceuticals securities during the Class Period

AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

(NASDAQ:AMLX), NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) on behalf of long-term stockholders following a class action complaint that was filed against Amylyx on July 1, 2025 with a Class Period from

Bragar Eagel & Squire, P.C. Is Investigating Apple, Abacus, Lineage, and CTO, and Encourages Investors to Contact the Firm

(NASDAQ:AAPL),(NASDAQ:ABL),(NASDAQ:LINE),(NYSE:CTO), NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Apple Inc. (NASDAQ:AAPL) Abacus Global Management, Inc. (NASDAQ:ABL), Lineage, Inc. (NASDAQ:LINE), and CTO Realty Growth, Inc. (NYSE:CTO). Our investigations concern whether these companies have violated the federal securities laws

Scroll to Top